Formins are a large family of actin assembly-promoting proteins with many important biological roles [1] [2] [3] . However, it has remained unclear how formins nucleate actin polymerization. All other nucleators are known to recruit actin monomers as a central part of their mechanisms [3] [4] [5] . However, the actin-nucleating FH2 domain of formins lacks appreciable affinity for monomeric actin [6, 7] . Here, we found that yeast and mammalian formins bind actin monomers but that this activity requires their C-terminal DAD domains. Furthermore, we observed that the DAD works in concert with the FH2 to enhance nucleation without affecting the rate of filament elongation. We dissected this mechanism in mDia1, mapped nucleation activity to conserved residues in the DAD, and demonstrated that DAD roles in nucleation and autoinhibition are separable. Furthermore, DAD enhancement of nucleation was independent of contributions from the FH1 domain to nucleation [8] . Together, our data show that (1) the DAD has dual functions in autoinhibition and nucleation; (2) the FH1, FH2, and DAD form a tripartite nucleation machine; and (3) formins nucleate by recruiting actin monomers and therefore are more similar to other nucleators than previously thought.
Summary
Formins are a large family of actin assembly-promoting proteins with many important biological roles [1] [2] [3] . However, it has remained unclear how formins nucleate actin polymerization. All other nucleators are known to recruit actin monomers as a central part of their mechanisms [3] [4] [5] . However, the actin-nucleating FH2 domain of formins lacks appreciable affinity for monomeric actin [6, 7] . Here, we found that yeast and mammalian formins bind actin monomers but that this activity requires their C-terminal DAD domains. Furthermore, we observed that the DAD works in concert with the FH2 to enhance nucleation without affecting the rate of filament elongation. We dissected this mechanism in mDia1, mapped nucleation activity to conserved residues in the DAD, and demonstrated that DAD roles in nucleation and autoinhibition are separable. Furthermore, DAD enhancement of nucleation was independent of contributions from the FH1 domain to nucleation [8] . Together, our data show that (1) the DAD has dual functions in autoinhibition and nucleation; (2) the FH1, FH2, and DAD form a tripartite nucleation machine; and (3) formins nucleate by recruiting actin monomers and therefore are more similar to other nucleators than previously thought.
Results and Discussion
The DAD Domain of mDia1 Enhances Actin Nucleation In earlier studies, a reported lack of G-actin binding affinity for the formin FH2 domain led to the hypothesis that formins might instead nucleate by stabilizing spontaneously formed actin dimers and/or trimers [6] . However, all other known actin nucleators actively recruit actin monomers [4, 5] . This left open the possibility that efficient nucleation by formins may involve actin-binding sequences located outside of the FH2 domain. Previous studies suggested that the FH1 domain enhances both nucleation and elongation by recruiting profilin-actin [6, [8] [9] [10] . However, the potential roles in nucleation of sequences C-terminal to the FH2 have remained unclear. WH2-like sequences have been identified in the C-terminal regions of several formins (FRL2, FRL3, and INF2), suggesting possible actin interactions [11, 12] . Furthermore, the C terminus of INF2 promotes actin assembly [11] . However, INF2 also severs filaments, making it difficult to assess whether the C terminus contributes specifically to nucleation. Here, we investigated this issue by comparing in several different formins the activities of FH1-FH2 constructs with and without additional C-terminal sequences.
We initially focused on mDia1 because it neither severs nor bundles filaments [11, 13] . We investigated DAD contributions to nucleation by comparing the actin assembly-promoting activities of freshly purified mDia1 polypeptides consisting of the FH1-FH2 region with and without the C-terminal DADcontaining region ( Figure 1A ). These two formin constructs are referred to herein as C and C-DDAD, respectively (see schematic in Figure 1A ). The activities of C and C-DDAD polypeptides were compared in pyrene-actin assembly assays over a range of concentrations in the presence and absence of profilin ( Figures 1B and 1C ). The C polypeptide had significantly higher activity than C-DDAD (example raw curves in Figures 1D and 1E) . This difference was substantial in the absence of profilin but even more pronounced in the presence of profilin. Earlier studies on mDia1 C and C-DDAD polypeptides did not note any differences in their activities (mDia1 C [8] ; mDia1 C-DDAD [14] ); however, the activities of the two constructs had been quantified in separate studies and thus not compared directly, nor in the presence of profilin where differences are greatest. In addition, we compared polypeptides immediately after purification, avoiding freeze-thawing, which we found can diminish DAD contributions.
Because bulk polymer assembly assays do not discern between formin effects on nucleation and elongation, we used time-lapse total internal reflection fluorescence (TIRF) microscopy to compare C and C-DDAD mDia1 effects on elongation rates of individual filaments ( Figure 1F ). In the presence of profilin, both mDia1 C and C-DDAD accelerated elongation by >5-fold (see Movie S1, Movie S2, and Movie S3 available online), as previously reported for mDia1 C [9] . Quantification of elongation rates revealed that there was no significant difference between C and C-DDAD polypeptides ( Figure 1G ), indicating that the differences in their actin assembly activities must be due to differences in nucleation. Consistent with these observations, C and C-DDAD polypeptides showed similar effects on barbed-end growth in seeded elongation assays with and without capping protein ( Figures S1A and S1B ). In addition, mDia1 C showed no filament-severing activity (Figure 1H) , as previously reported [11] . Taken together, these data show that the C terminus of mDia1 makes a substantial contribution to actin nucleation without affecting rate of elongation or protection from capping protein.
Similar differences in the actin assembly activities of C and C-DDAD polypeptides were observed for three other formins, Bni1, Bnr1, and Daam1 ( Figure S2 ), suggesting that the role of the C terminus in nucleation could be conserved. Differences were most striking for Daam1, where loss of the C terminus caused a >30-fold decrease in assembly activity ( Figure S2D ). None of these formins exhibited severing activity, indicating that the C terminus in each case contributes to de novo actin assembly ( Figure S2E ). However, further analysis *Correspondence: goode@brandeis.edu will be required to determine whether these DAD contributions to actin assembly are due to effects on nucleation and not elongation as in mDia1.
Identification of Residues in DAD that Mediate Actin Nucleation
Next, we mapped the nucleation activity of the mDia1 C terminus. Our mDia1 C and C-DDAD polypeptides differed by 76 residues (549-1255 and 549-1179, respectively). We first tested whether sequences C-terminal to the DAD motif contribute to nucleation. For this, we generated a new truncation, mDia1 C-DCT (549-1200), and compared its activity to mDia1 C. We observed no difference in their activities over a range of concentrations ( Figure S3A ), suggesting that nucleation activity in the mDia1 C terminus stems from sequences in the DAD domain itself. Next, we used site-directed mutagenesis to dissect the nucleation activity. Structural studies on DAD have shown . Open black circles indicate residues mutated in the m1-m5 alleles of mDia1 C: m1 (E1175A, D1177A, E1178A), m2 (M1182A, L1185A), m3 (D1182A, L1186A), m4 (Q1190A, S1191A), and m5 (K1198E, R1199E). Red dots indicate residues known to mediate autoinhibition [15, 16, 18, 19] .
(B and C) Pyrene-actin (2 mM, 5% labeled) was assembled with different concentrations of wildtype or mutant mDia1 C polypeptides in the absence (B) or presence (C) of 5 mM profilin.
Rates of assembly were determined from the slopes of assembly curves.
(D and E) Raw curves for mDia1 C and mDia1 C (m5) in the presence of 5 mM profilin.
(F) Pyrene-actin was assembled as in (C) using 2 nM wild-type and mutant mDia1 C polypeptides and variable concentrations of N-mDia1. Rates of assembly were determined from the raw curves and graphed.
that it consists of a short amphipathic helix followed by an unstructured sequence rich in basic residues [15] [16] [17] . In addition, mutational and structural analyses have identified specific residues in DAD that mediate autoinhibitory interactions with the N-terminal DID domain [15, 16, 18, 19] . From an alignment of DAD sequences, we identified conserved residues (Figure 2A , open black circles). We designed five alleles ( Figure 2A , m1-m5) that collectively mutate 11 residues, including some known to be important for autoinhibition ( Figure 2A , red dots). We purified wildtype and mutant mDia1 C polypeptides and compared their actin assembly activities in the absence and presence of profilin ( Figures 2B and 2C ). One mutant (m5) showed a severe loss of nucleation activity, comparable to deleting the entire DAD (raw curves in Figures  2D and 2E ). Another mutant (m4) showed a partial loss of activity. The remaining three mutants (m1, m2, m3) had activities similar to wild-type mDia1 C. These results suggest that one or both of the residues mutated in m5 (K1198E and R1199E) are critical for DAD nucleation activity and that the residues mutated in m4 (Q1190A and S1191A) make a smaller contribution.
We also investigated the relationship between nucleation and autoinhibition mediated by DAD by comparing the activities of wild-type and mutant mDia1 C polypeptides (2 nM) in the presence of different concentrations of a DID-containing fragment (N-mDia1) ( Figure 2F ). The activity of wild-type mDia1 C was inhibited in trans by N-mDia1 in a concentration-dependent manner, reaching 50% inhibition at 2-3 nM N-mDia1, as previously reported [8] . Inhibition of m1, m4, and m5 mutant mDia1 C polypeptides was similar to wild-type, whereas m2 and m3 mutant polypeptides were refractory to inhibition. These results are consistent with m2 and m3 having weakened DAD-DID interactions, as predicted [17] . Taken together, these observations show that m4 and m5 impair nucleation without affecting autoinhibition, whereas m2 and m3 impair autoinhibition without affecting nucleation. Thus, DAD functions in autoinhibition and nucleation are separable.
DAD Domain Binding to Actin Monomers
The simplest mechanism to explain how DAD might enhance nucleation is by directly binding actin. To test this, we compared the abilities of mDia1 C and C-DDAD polypeptides to affect the fluorescence signal of pyrene-G-actin under conditions that prevent polymerization (250 nM actin and 400 nM latrunculin B). Under these conditions, mDia1 C induced a concentration-dependent increase in pyrene-actin signal, suggesting binding. In contrast, C-DDAD had no significant effect on pyrene-actin fluorescence (Figure 3A) , suggesting that DAD is required for binding to G-actin. Mutant mDia1 C(m5) showed altered effects on pyrene-actin fluorescence compared to wild-type mDia1 C, suggesting that this mutation changes some aspect of DAD interactions with G-actin. However, the data did not suggest that the m5 mutation changed the affinity of actin binding. The observation that DAD is critical for C polypeptide binding to G-actin agrees with previous studies showing that FH2 (lacking DAD) has little, if any, affinity for G-actin [6, 7] . Next, we asked whether a DAD peptide alone (no FH2) is sufficient to bind G-actin by testing interactions between pyrene-G-actin and mDia1 DAD (1175-1200) fused to maltosebinding protein (MBP). MBP-DAD induced a concentration-dependent increase in pyrene-G-actin fluorescence, consistent with G-actin binding, whereas MBP alone had no effect ( Figure 3B ). Further addition of profilin, even as high as 200 mM, did not alter MBP-DAD interactions with pyrene-Gactin ( Figure S3F ), suggesting that DAD and profilin do not compete for actin binding. Mutant MBP-DAD(m5) showed altered effects on fluorescence, again consistent with this mutation altering some aspect of the DAD interaction with G-actin.
The DAD regions of Bni1 and Bnr1 are also critical for G-actin binding. This was evident from a comparison of the effects of Bnr1 C, Bnr1 C-DDAD, Bni1 C, and Bni1 C-DDAD polypeptides on pyrene-G-actin fluorescence (Figures S3B  and S3C ). In addition, DAD peptides of Bni1 (1750-1858) and Bnr1 (1274-1342) induced concentration-dependent increases in pyrene-G-actin fluorescence (Figures S3D and  S3E) . Although the binding affinities of DAD peptides for G-actin were very low, our nucleation data argue that these actin-binding sites make important contributions to nucleation in the context of an intact formin, i.e., where two DAD domains are physically tethered to an FH2 dimer. In addition, note that our data argue that the FH2 makes a critical contribution to G-actin binding. This is reflected in the major difference in G-actin binding affinities between DAD and FH2-DAD. Thus, although DAD alone is sufficient for weak autonomous interactions with G-actin, binding is strengthened substantially by inclusion of the FH2, even though FH2 alone shows no detectable binding. was observed for MBP-DAD at concentrations as high as 50 mM ( Figure S4B ), significant nucleation effects were observed for GST-DAD at concentrations as low as 1 mM ( Figure 3C ). This difference in activity between MBP and GST fusions suggested that nucleation might arise as a result of GST dimerization tethering two DAD domains together. This led us to also ask whether DAD domains can support nucleation in the context of an intact dimeric formin when the actin binding/nucleation activity of the FH2 is disrupted. To test this idea, we introduced into mDia1 C, mDia1 C-DDAD, and mDia1 C(m5) the I845A mutation, which severely disrupts actin binding and nucleation by the FH2 [7, 13] . Compared to wild-type mDia1 C, mDia1 C (I845A) showed drastically reduced nucleation activity, requiring >100-fold higher concentration to produce similar levels of activity (Figure 3D ). Combining I845A with a truncation of DAD abolished the residual nucleation activity, as did combining m5 and I845A ( Figure 3G ; raw curves in Figures  3E and 3F ). These data suggest that when two DAD domains are physically tethered to the FH2 dimer, they support a modest level of nucleation activity, which is also consistent with our GST-DAD results.
FH1 and DAD Domains Make Separate Contributions to Nucleation
Previous studies have suggested that in the presence of profilin, the FH1 domain of mDia1 enhances nucleation by the FH2 [8, 10] . We purified mDia1 C-DFH1 ( Figure 4A ) and observed that indeed it had much weaker actin assembly activity compared to mDia1 C in the presence of profilin over a wide range of formin concentrations (Figures 4B-4D) .
Specifically, an almost 30-fold higher concentration of mDia1 C-DFH1 was required to support the same activity level as mDia1 C (compare the light blue curve in Figure 4B and the dark blue curve in Figure 4C ). Even accounting for a 5-fold elongation effect, this suggests that the FH1 makes a substantial contribution to nucleation. Consistent with this view, we directly visualized an increase (>10-fold) in the number of filaments assembled by mDia1 C compared to mDia1 C-DFH1 ( Figures S4D and S4E ). As expected, no difference in the activities of mDia1 C-DFH1 and mDia1 C was observed in the absence of profilin (Figure 4 ; raw curves in Figure S4C ). These data confirm that in the presence of profilin, the FH1 contributes to nucleation. On the other hand, DAD enhanced nucleation both in the presence of profilin, at a range of profilin concentrations ( Figure 4F) , and in the absence of profilin (Figure 1B) . Furthermore, at very high profilin concentrations (50 mM and above) that inactivate FH1 contributions to actin assembly by competitively blocking profilin-actin recruitment, DAD is instrumental for nucleation ( Figure 4G ).
Conclusions
The DAD domain was first defined as a sequence in the C terminus of diaphanous-related formins that mediates autoinhibition through intramolecular interactions with the formin N terminus [18] . Since then, this motif has been identified in a large number of formins, including members of at least 4 of the 7 formin subfamilies in diverse organisms [20, 21] . However, recent findings suggest that not all formins carrying DAD domains are autoinhibited, including Schizosaccharomyces pombe Cdc12; Drosophila melanogaster Cappucino; and mammalian delphilin, FRL2, and INF2 [22] . This observation raises the possibility that the DAD has been maintained in these formins to perform other functions. Our data show that the DAD domain of mDia1 binds to actin monomers and strongly enhances the nucleation activity of the FH2 domain. This function may extend to other formins, because we found that the DAD regions of Saccharomyces cerevisiae Bni1 and Bnr1 are required for G-actin binding and enhance actin assembly in these formins ( Figures  S3B-S3D) . Thus, our view of the formin nucleation mechanism has changed substantially from one in which the FH2 acts alone to one in which the FH1, FH2, and DAD domains act in concert as a tripartite nucleation apparatus, combining Gactin and profilin-G-actin recruitment sites with high-affinity filament end-capturing activity.
Another central conclusion we draw from our results is that the DAD performs dual roles in actin nucleation and autoinhibition. This suggests two interesting mechanistic parallels between formins and the N-WASP-Arp2/3 complex. First, formins and Arp2/3 both nucleate actin assembly by combining an actin monomer recruitment domain (DAD in formins; VCA in N-WASP) and a filament end-capturing unit (FH2 dimer in formins; actin-related protein dimer in Arp2/3). In each nucleating system, the end-capturing unit is pivotal for nucleation and the monomer recruitment domain strongly enhances the activity. Second, in each case, the monomer recruitment domain can have dual roles in nucleation and autoinhibition. This general strategy of masking sites important for activity in the autoinhibited state that become available upon release and/or activation is common to autoinhibited proteins with a variety of cellular functions [23] .
Finally, our data also indicate that the formin nucleation mechanism is more similar to those of other actin assembly factors than previously thought. Spire, Cobl, Lmod, JMY, and APC each recruit two to four actin monomers using tandem arrays of actin-binding motifs (often WH2 domains) to form prenucleation complexes [3] . Furthermore, the nucleation activity of Arp2/3 depends strongly on its association with N-WASP and the ability of N-WASP to recruit monomers. Until now, formins have been proposed to use a distinct mechanism of nucleation involving capture of spontaneously formed actin dimers and/or trimers. However, such a mechanism does not adequately explain how nucleation would occur in vivo, where an abundance of actin monomer-binding proteins are thought to suppress spontaneous dimer and trimer formation. Instead, we have shown that formins recruit actin monomers to enhance nucleation through interactions of their DAD domains with G-actin. Thus, actin monomer recruitment appears to be a universal property of all currently known actin nucleators.
Experimental Procedures Actin Assembly and Disassembly Assays
Purification of all proteins is described in Supplemental Experimental Procedures. Gel-filtered monomeric actin (2 mM final; 5% pyrene labeled) in G-buffer (10 mM Tris [pH 8.0], 0.2 mM ATP, 0.2 mM CaCl 2 , 0.2 mM dithiothreitol [DTT]) was converted to Mg-ATP-actin immediately before each reaction. Actin was mixed with 15 ml of proteins or control buffer (HEKG 5 ) and 3 ml of 203 initiation mix (40 mM MgCl 2 , 10 mM ATP, 1 M KCl). For reactions containing profilin, S. cerevisiae profilin was used with Bni1 and Bnr1, and human platelet profilin was used with mDia1 and Daam1. Pyrene fluorescence was monitored for 10 min at excitation 365 nm and emission 407 nm at 25 C in a fluorescence spectrophotometer (Photon Technology International) or an Infinite M200 plate reader (Tecan). Rates of assembly were calculated from slopes of the curves at 50% polymerization, except when reactions failed to reach 50% polymerization during the 10 min; in these cases, slopes were measured at the steepest points in the curves. Disassembly assays were performed using preassembled F-actin (10% pyrene labeled). Briefly, the preassembled F-actin (2 mM) was incubated with formin constructs or Cof1 for 300 s, and 4 mM vitamin D-binding protein (human plasma Gc-globulin, Sigma-Aldrich) was then added to initiate disassembly.
G-Actin Binding Assays
Pyrene-G-actin (250 nM, 100% labeled) was incubated for 15 min at room temperature in the presence of 500 nM latrunculin B with mDia1 C, mDia1 C-DDAD, or mDia1 C(m5) in HEKG 5 buffer (25 mM HEPES [pH 7.5], 50 mM KCl, 1 mM EDTA, 5% glycerol), and pyrene fluorescence was measured as above. For reactions containing wild-type and mutant m5 mDia1 MBPHis 6 -mDia1-DAD (1175-1200), the buffer was 25 mM Tris (pH 8.0), 200 mM NaCl, 50 mM L-arginine. Salt composition of the buffer was varied from 0 to 200 mM NaCl with no alteration in MBP-mDia1 DAD effects on pyrene fluorescence.
TIRF Microscopy
Freely diffusing F-actin filaments were polymerized in bovine serum albumin-coated chambers. Reactions contained 1 mM monomeric actin (30% labeled), 3 mM human profilin, and 2 nM mDia1 C or C-DDAD polypeptides. To induce actin polymerization, we diluted protein mixtures into freshly prepared fluorescence buffer containing 10 mM imidazole-HCl (pH 7.8), 50 mM KCl, 1 mM MgCl 2 , 100 mM DTT, 3 mg/ml glucose, 20 mg/ml catalase, 100 mg/ml glucose oxidase, 0.5% methylcellulose. Elongation of the barbed end of filaments was monitored as increase in length over time, as described previously [24] . Samples were imaged at 20 s intervals on an Olympus IX-71 inverted microscope equipped with a 603/1.45 NA Plan Apo objective (Olympus) and modified as described previously [25] to receive TIRF illumination. Samples were illuminated with an argon/krypton laser (CVI Melles Griot) emitting at 488 nm. Images were acquired with a Hamamatsu ORCA-ER camera (Hamamatsu Photonics Deutschland GmbH) running MetaMorph version 6.2r6 software (Universal Imaging).
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